STE.NYSESteris PLC

Form 4: STERIS plc: Insider Sells Shares for Tax Withholding

Sentiment:

Statement of Changes in Beneficial Ownership


John Adam Zangerle, Sr. VP, Gen Counsel, and Sec. of STERIS plc, reported a transaction involving the sale of 401 ordinary shares to cover tax withholding obligations.

Summary

  • John Adam Zangerle, Sr. VP, General Counsel, and Secretary of STERIS plc, reported a transaction on June 4, 2026.
  • This transaction involved the withholding of 401 ordinary shares from a vesting of 1,376 restricted shares.
  • The withheld shares were used to cover applicable employment or tax law obligations, valued at the NYSE closing market price on June 4, 2026, which was $212.24 per share.
  • Following this transaction, Zangerle beneficially owns 36,678 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine administrative transaction for tax purposes rather than a strategic financial event.

Positives

  • The transaction is a standard tax withholding event, indicating compliance with tax regulations.
  • The company has a clear process for managing tax liabilities associated with share vesting.

Negatives

  • A portion of vested shares were sold, reducing the reporting person's direct holdings.

Risks

  • The filing does not explicitly mention any risks.
  • Potential future tax law changes could impact the number of shares withheld in similar transactions.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a report of a past transaction.

Management Comments

  • "These 401 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer."
  • "These vested shares were valued at the NYSE closing market price on June 4, 2026."

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions, often related to compensation plans, tax obligations, or personal investment decisions. This specific filing indicates a standard practice for managing tax liabilities associated with executive compensation in the healthcare technology sector.

Stakeholder Impact

  • Shareholders: Minimal direct impact, as this is a standard tax-related transaction by an executive and does not represent a sale of shares for personal profit beyond tax obligations.
  • Employees: The transaction is a consequence of the company's compensation and tax policies, which affect employees receiving equity awards.
  • Management: Reflects the execution of the company's equity compensation and tax management strategies.

Next Steps

  • The remaining restricted shares will lapse according to the schedule provided in the filing.
  • Future transactions by John Adam Zangerle will be reported on subsequent Form 4 filings.

Key Dates

DateDescription
06/04/2026Transaction date for share withholding and vesting.
06/08/2026Date of the filing and signature.
06/02/2027Lapse date for 1,453 restricted ordinary shares.
06/03/2027Lapse date for 1,252 restricted ordinary shares.
06/04/2027Lapse date for 1,376 restricted ordinary shares.
06/02/2028Lapse date for 1,453 restricted ordinary shares.
06/05/2028Lapse date for 1,252 restricted ordinary shares.
06/04/2029Lapse date for 1,453 restricted ordinary shares.

Keywords

STERIS plc, STE, Form 4, Insider Transaction, Tax Withholding, Share Vesting, Beneficial Ownership, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.